Riley Jeffrey Scott - Insider Non-Derivative Transactions at Gain Therapeutics, Inc. (GANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 28, 2024, Riley Jeffrey Scott's relationship to Gain Therapeutics, Inc. (GANX) is Director, and currently has 30,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GANX insiders.
Data Source: SEC.
Riley Jeffrey Scott - Insider Non-Derivative Transactions at GANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 29, 2024 | P -- (Common Stock) | 30000 | 3.86 | 30000 |